Acute Coronary Syndrome Following Long-Term Erlotinib Treatment

Data publikacji: 20 lip 2018

Zakres stron: 61 - 66

DOI: https://doi.org/10.2478/inmed-2018-0023

Słowa kluczowe

Erlotinib, tyrosine kinase inhibitor, non-small cell lung cancer, acute coronary syndrome

© 2018 Traian Constantin Panciu et al., published by Sciendo

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.